Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Lilly prepares water-soluble echinocandin antifungal agents

April 25, 1997

Roussel Uclaf claims new cephalosporins

April 25, 1997

Final FDA approval for Faulding's acyclovir injection

April 24, 1997

Sch-56592 in phase II trials for fungal infections

April 24, 1997

Buckminsterfullerene photodynamically inactivates enveloped viruses

April 23, 1997

Roche reveals cephalosporins

April 22, 1997

Meiji Seika describes potent, broad-spectrum carbapenems

April 22, 1997

FDA advisory committee rejects Amphotec supplemental NDA

April 21, 1997

Zagam available in Germany

April 18, 1997

ImmuCell to initiate clinical trial of DiffGAM

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...